dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.
mvasi 400 mg/16ml vial
مفاسي 400مجم16مل فيال
bevacizumab · 400 mg/16ml
17081EGP
Available
Active ingredient
bevacizumab
Strength
400 mg/16ml
Form
vial
Manufacturer
amgen > amgen scientific office
Route
injection

Uses

Used in combination regimens for various cancers including colorectal cancer, non-small cell lung cancer, renal cell carcinoma, and others.

Do not use if

No formal absolute contraindications are listed, but severe hypersensitivity warrants discontinuation.

Side effects

May cause hypertension, bleeding, thromboembolism, proteinuria, wound-healing complications, and gastrointestinal perforation.

Warnings

Monitor for serious bleeding, thromboembolic events, wound-healing complications, and gastrointestinal perforation.

How it works

A monoclonal antibody that binds VEGF and inhibits tumor angiogenesis.

Storage

Store refrigerated at 2°C to 8°C. Do not freeze or shake.